Role of tumor necrosis factor-α in the pathogenesis of indomethacin-induced small intestinal injury in mice

International Journal of Molecular Medicine

Volumn 27, Issue 3, 2011, Pages 353-359

  Fukumoto, Kohei ^a   Naito, Yuji ^a   Takagi, Tomohisa ^a   Yamada, Shinya ^a   Horie, Ryusuke ^a   Inoue, Ken ^a   Harusato, Akihito ^a   Hirata, Ikuhiro ^a   Omatsu, Tastushi ^a   Mizushima, Katsura ^a   Hirai, Yasuko ^a   Yoshida, Naohisa ^a   Uchiyama, Kazuhiko ^a   Ishikawa, Takeshi ^a   Handa, Osamu ^a   Konishi, Hideyuki ^a   Wakabayashi, Naoki ^a   Yagi, Nobuaki ^a   Kokura, Satoshi ^a   Ichikawa, Hiroshi ^a   Kita, Masakazu ^a   Yoshikawa, Toshikazu ^a   more..

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Apoptosis; Indomethacin; Small intestine; Tumor necrosis factor

Indexed keywords

CASPASE 3; INDOMETACIN; MESSENGER RNA; MYELOPEROXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOLOGY; INTESTINE ULCER; MALE; MOUSE; NEUTROPHIL; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SMALL INTESTINE DISEASE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CASPASE 3; CHEMOKINE CXCL1; EPITHELIAL CELLS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; INDOMETHACIN; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; MICE; MICE, KNOCKOUT; PEROXIDASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79551588521     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.602     Document Type: Article

References (31)

1. Iddan G, Meron G, Glukhovsky A and Swain P: Wireless capsule endoscopy. Nature 405: 417, 2000.
2. Meron GD: The development of the swallowable video capsule (M2A). Gastrointest Endosc 52: 817-819, 2000.
3. Yamamoto H, Sekine Y, Sato Y, et al: Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointest Endosc 53: 216-220, 2001.
4. Morris AJ, Madhok R, Sturrock RD, Capell HA and MacKenzie JF: Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet 337: 520, 1991.
5. Allison MC, Howatson AG, Torrance CJ, Lee FD and Russell RI: Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 327: 749-754, 1992.
6. Bjarnason I, Hayllar J, MacPherson AJ and Russell AS: Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 104: 1832-1847, 1993.
7. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S and Fort JG: Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 3: 133-141, 2005.
8. Tracey KJ and Cerami A: Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 45: 491-503, 1994.
9. Rutgeerts PJ: Review article: efficacy of infliximab in Crohn's disease - induction and maintenance of remission. Aliment Pharmacol Ther 13 (Suppl. 4): S9-S15; discussion 38, 1999.
10. Naito Y, Takagi T, Handa O, et al: Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice. J Gastroenterol Hepatol 18: 560-569, 2003.
11. Bertrand V, Guimbaud R, Tulliez M, et al: Increase in tumor necrosis factor-alpha production linked to the toxicity of indomethacin for the rat small intestine. Br J Pharmacol 124: 1385-1394, 1998.
12. Nandi J, Saud B, Zinkievich JM, Yang ZJ and Levine RA: TNF-alpha modulates iNOS expression in an experimental rat model of indomethacin-induced jejunoileitis. Mol Cell Biochem 336: 17-24, 2010.
13. Watanabe T, Higuchi K, Kobata A, et al: Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 57: 181-187, 2008.
14. Cury DH, Costa JE, Irika K, et al: Protective effect of octreotide and infliximab in an experimental model of indomethacin-induced inflammatory bowel disease. Dig Dis Sci 53: 2516-2520, 2008.
15. Taniguchi T, Takata M, Ikeda A, Momotani E and Sekikawa K: Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor alpha-deficient mice. Lab Invest 77: 647-658, 1997
16. Konaka A, Kato S, Tanaka A, Kunikata T, Korolkiewicz R and Takeuchi K: Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats. Pharmacol Res 40: 517-524, 1999.
17. Konaka A, Nishijima M, Tanaka A, Kunikata T, Kato S and Takeuchi K: Nitric oxide, superoxide radicals and mast cells in pathogenesis of indomethacin-induced small intestinal lesions in rats. J Physiol Pharmacol 50: 25-38, 1999.
18. Grisham MB, Hernandez LA and Granger DN: Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 251: G567-G574, 1986.
19. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
20. Kahky MP, Daniel CO, Cruz AB and Gaskill HV III: Portal infusion of tumor necrosis factor increases mortality in rats. J Surg Res 49: 138-145, 1990.
21. Gitter AH, Bendfeldt K, Schmitz H, Schulzke JD, Bentzel CJ and Fromm M: Epithelial barrier defects in HT-29/B6 colonic cell monolayers induced by tumor necrosis factor-alpha. Ann NY Acad Sci 915: 193-203, 2000.
22. Abreu-Martin MT, Vidrich A, Lynch DH and Targan SR: Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J Immunol 155: 4147-4154, 1995.
23. Asako H, Kubes P, Wallace J, Gaginella T, Wolf RE and Granger DN: Indomethacin-induced leukocyte adhesion in mesenteric venules: role of lipoxygenase products. Am J Physiol 262: G903-G908, 1992.
24. Boushey RP, Yusta B and Drucker DJ: Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis. Am J Physiol 277: E937-E947, 1999.
25. Kamil R, Geier MS, Butler RN and Howarth GS: Lactobacillus rhamnosus GG exacerbates intestinal ulceration in a model of indomethacin-induced enteropathy. Dig Dis Sci 52: 1247-1252, 2007
26. Fuji Y, Matsura T, Kai M, Kawasaki H and Yamada K: Protection by polaprezinc, an anti-ulcer drug, against indomethacin-induced apoptosis in rat gastric mucosal cells. Jpn J Pharmacol 84: 63-70, 2000.
27. Nagano Y, Matsui H, Muramatsu M, et al: Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells. Dig Dis Sci 50 (Suppl. 1): S76-S83, 2005.
28. Omatsu T, Naito Y, Handa O, et al: Reactive oxygen species-quenching and anti-apoptotic effect of polaprezinc on indomethacin-induced small intestinal epithelial cell injury. J Gastroenterol 45: 692-702, 2010.
29. Bazzoni F and Beutler B: The tumor necrosis factor ligand and receptor families. N Engl J Med 334: 1717-1725, 1996.
30. Takada M, Otaka M, Takahashi T, et al: Overexpression of a 60-kDa heat shock protein enhances cytoprotective function of small intestinal epithelial cells. Life Sci 86: 499-504, 2010.
31. Asano T, Tanaka K, Yamakawa N, et al: HSP70 confers protection against indomethacin-induced lesions of the small intestine. J Pharmacol Exp Ther 330: 458-467, 2009.